Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.750
+0.180 (5.04%)
At close: Mar 6, 2026, 4:00 PM EST
3.670
-0.080 (-2.13%)
After-hours: Mar 6, 2026, 7:52 PM EST
Whitehawk Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Whitehawk Therapeutics stock has a target of 7.00, which predicts an increase of 86.67% from the current stock price of 3.75.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 22, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Whitehawk Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +86.67% | Dec 22, 2025 |
Financial Forecast
Revenue This Year
7.25M
from 25.98M
Decreased by -72.10%
Revenue Next Year
n/a
from 7.25M
EPS This Year
-0.28
from -2.36
EPS Next Year
-1.30
from -0.28
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.5M | n/a | ||||
| Avg | 7.3M | n/a | ||||
| Low | 6.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -71.1% | - | ||||
| Avg | -72.1% | - | ||||
| Low | -73.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.26 | -1.14 | |
| Avg | -0.28 | -1.30 | |
| Low | -0.29 | -1.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.